Sorrento Therapeutics Inc (SRNE)

[dia76ca]

I agree that March and April will see important advances in at least 6 Covid programs.

1. STIX-expected EUA approval

2. MSC (P2) application for EUA in March/April. The magic number of patients is 40 with good data.

3.Abivertinib (covid) Sorrento has enrolled over 60+ patients and has 5 locations, but the magic number again with good data is 40. Expect EUA application in late March.

4.Covi-GeneMab approved for P1

5. Covi-Drops approved for P1b/P2 (it’s just at matter of figuring out the right dosage level).

6. COVI-AMG-The FDA is expediting the approval process even more for covid drugs of late. EUA in March/April. Testing is currently being done in US, Brazil, and Mexico.

Of course OWS and government contracts and grants should be expected along the way. There is a good chance most of these will be advanced. Covid is a worldwide pandemic and likely will need to be dealt with for many years around the world.

And we shouldn't forget that both the DAR-T and second generation Oncolytic Virus should enter the clinic. And the NK and Celularity investments values should continue to increase. I expect they'll be worth a billion ...as will the PSS lawsuit settlement ! And the steadily increasing institutional ownership accumulation will bring us to the point where they're ready to move the share price dramatically !